Preclinical Studies of RUC-4, a Novel Platelet αIIbβ3 Antagonist, in Non-Human Primates and With Human Platelets.

Authors

Spandana Vootukuri
Jihong Li
Mark Nedelman
Craig Thomas
Jiang-Kang Jiang
Mariana Babayeva, Touro College
Barry S. Coller

Publication Date

6-2019

DOI

10.1017/cts.2019.382

Recommended Citation

Vootukuri, S., Li, J., Nedelman, M., Thomas, C., Jiang, J.-K., Babayeva, M., & Coller, B. S. (2019). Preclinical Studies of RUC-4, a Novel Platelet αIIbβ3 Antagonist, in Non-Human Primates and With Human Platelets. Journal of Clinical and Translational Science, 3(2–3), 65–74. https://doi.org/10.1017/cts.2019.382